title: Long-Term Maintenance of Improvements in Multiple Facets of Psoriatic Arthritis With Certolizumab Pegol: 96-Week Patient-Reported Outcome Results Of The Rapid-Psa Study.
authors.affiliation: Toronto Western Research Institute, Toronto, Ontario, ON, Canada.
authors.forename: D
authors.initials: D
authors.lastname: Gladman
authors.affiliation: Metroplex Clinical Research Center, Dallas, TX, USA.
authors.forename: R
authors.initials: R
authors.lastname: Fleischmann
authors.affiliation: UCB Pharma, Brussels, Belgium.
authors.forename: B
authors.initials: B
authors.lastname: Szegvari
authors.affiliation: UCB Pharma, Raleigh, NC, USA.
authors.forename: L
authors.initials: L
authors.lastname: Peterson
authors.affiliation: Swedish Medical Center and University of Washington, Seattle, WA, USA.
authors.forename: P J
authors.initials: PJ
authors.lastname: Mease